Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
Clinical Endocrinology|December 1, 1979
An 'artificial beta cell' for control of diabetes mellitus: effect on plasma glucagon levelsD L Horwitz, B Gonen, J B Jaspan, et al.
Natural Immunity and Cell Growth Regulation|January 1, 1986
Marker and function analysis of natural killer and alloreactive T cells during early stages of dimethylbenzanthracene carcinogenesis. The immunity system during the precancer periodR Ehrlich, B Gonen, E Sahar, et al.
Biochemical and Biophysical Research Communications|October 29, 1987
Low density lipoprotein (LDL) inhibits histamine release from human mast cellsE S Schulman, T J Quinn, T J Post, et al.
Journal of Dentistry|July 17, 2022
Transforming growth factor β1-enriched secretome up-regulate osteogenic differentiation of dental pulp stem cells, and a potential therapeutic for gingival wound healing: A comparative proteomics studyH Salkin, M B Acar, S Korkmaz, et al.
Journal of Diabetes and Its Complications|July 1, 1993
Withdrawal of the aldose reductase inhibitor tolrestat in patients with diabetic neuropathy: effect on nerve function. The Tolrestat Study GroupJ V Santiago, P H Snksen, A J Boulton, et al.
Reproductive Toxicology (Elmsford, N.Y.)|August 20, 2025
Role of adipose-derived stem cell exosomes in paclitaxel-induced acute ovarian injury: An experimental approachBetul Yalcın, Tugce K Kalkan, Zeynep B Gonen, et al.
Journal of Biochemical and Molecular Toxicology|September 2, 2022
Bone marrow-derived mesenchymal stem cells alleviate paclitaxel-induced mechanical allodynia in ratsGulay Sezer, Arzu H Yay, Zeynep S Sarica, et al.
Immunobiology|August 1, 1992
Possibilities of interference with the immune system of tumor bearers by non-lymphoid Fc gamma RII expressing tumor cellsM Ran, A B Langer, I Eliassi, et al.
Diabetes|August 1, 1979
Metabolic control in diabetic patients. Effect of insulin-secretory reserve (measured by plasma C-peptide levels) and circulating insulin antibodiesB Gonen, J Goldman, D Baldwin, et al.
Journal of Diabetes and Its Complications|July 1, 1993
Effect of hyperglycemia and the aldose reductase inhibitor tolrestat on sural nerve biochemistry and morphometry in advanced diabetic peripheral polyneuropathy. The Tolrestat Study GroupA A Sima, D A Greene, M B Brown, et al.
Pageof 7